Psychiatry - Pathology (2) Flashcards
(40 cards)
1
Q
Specific phobia
- Definition
- Treatment
- Social anxiety disorder
- Definition
- Treatment
- Agoraphobia
A
- Definition
- Fear that is excessive or unreasonable and interferes with normal function.
- Cued by presence or anticipation of a specific object or situation.
- Person recognizes fear is excessive.
- Treatment
- Can treat with systematic desensitization.
-
Social anxiety disorder
- Definition
- Exaggerated fear of embarrassment in social situations (e.g., public speaking, using public restrooms).
- Treatment
- SSRIs.
- Definition
-
Agoraphobia
- Exaggerated fear of open or enclosed places, using public transportation, being in line or in crowds, or leaving home alone.
2
Q
Generalized anxiety disorder
- Definition
- Treatment
- Adjustment disorder
A
- Definition
- Pattern of uncontrollable anxiety for at least 6 months that is unrelated to a specific person, situation, or event.
- Associated with sleep disturbance, fatigue, GI disturbance, and difficulty concentrating.
- Treatment
- SSRIs, SNRIs, buspirone, cognitive behavioral therapy.
-
Adjustment disorder
- Emotional symptoms (anxiety, depression) causing impairment following an identifiable psychosocial stressor (e.g., divorce, illness) and lasting < 6 months (> 6 months in presence of chronic stressor).
3
Q
Obsessive-compulsive disorder
- Definition
- Treatment
- Ego dystonic
- Body dysmorphic disorder
A
- Definition
- Recurring intrusive thoughts, feelings, or sensations (obsessions) that cause severe distress
- Associated with Tourette disorder.
- Treatment
- Relieved in part by the performance of repetitive actions (compulsions)
- SSRIs, clomipramine.
- Ego dystonic
- Behavior inconsistent with one’s own beliefs and attitudes (vs. obsessive-compulsive personality disorder)
-
Body dysmorphic disorder
- Preoccupation with minor or imagined defect in appearance, leading to significant emotional distress or impaired functioning
- Patients often repeatedly seek cosmetic surgery.
4
Q
Post-traumatic stress disorder
- Definition
- Treatment
- Acute stress disorder
A
- Definition
- Persistent reexperiencing of a previous traumatic event (e.g., war, rape, robbery, serious accident, fire).
- May involve nightmares or flashbacks, intense fear, helplessness, or horror.
- Leads to avoidance of stimuli associated with the trauma and persistently increased arousal.
- Disturbance lasts > 1 month, with onset of symptoms beginning anytime after event, and causes significant distress, negative cognitive alterations, and/or impaired functioning.
- Treatment
- Psychotherapy, SSRIs.
-
Acute stress disorder
- Lasts between 3 days and 1 month.
5
Q
Malingering
A
- Patient consciously fakes, profoundly exaggerates, or claims to have a disorder in order to attain a specific 2° (external) gain (e.g., avoiding work, obtaining compensation).
- Poor compliance with treatment or follow-up of diagnostic tests.
- Complaints cease after gain (vs. factitious disorder).

6
Q
Factitious disorders
- Definition
- Munchausen syndrome
- Munchausen syndrome by proxy
A
- Definition
- Patient consciously creates physical and/or psychological symptoms in order to assume “sick role” and to get medical attention (1° [internal] gain).
- Munchausen syndrome
- Chronic factitious disorder with predominantly physical signs and symptoms.
- Characterized by a history of multiple hospital admissions and willingness to receive invasive procedures.
- Munchausen syndrome by proxy
- When illness in a child or elderly patient is caused by the caregiver.
- Motivation is to assume a sick role by proxy.
- Form of child/elder abuse.
7
Q
Somatic symptom and related disorders
- Definition
- Somatic symptom disorder
- Conversion disorder
- Illness anxiety disorder (hypochondriasis)
A
- Definition
- Category of disorders characterized by physical symptoms with no identifiable physical cause.
- Both illness production and motivation are unconscious drives.
- Symptoms not intentionally produced or feigned.
- More common in women.
- Somatic symptom disorder
- Variety of complaints in one or more organ systems lasting for months to years.
- Associated with excessive, persistent thoughts and anxiety about symptoms.
- May co-occur with medical illness.
- Conversion disorder
- Sudden loss of sensory or motor function (e.g., paralysis, blindness, mutism), often following an acute stressor
- Patient is aware of but sometimes indifferent toward symptoms (“la belle indifférence”)
- More common in females, adolescents, and young adults.
- Illness anxiety disorder (hypochondriasis)
- Preoccupation with and fear of having a serious illness despite medical evaluation and reassurance.
8
Q
Personality
- Personality trait
- Personality disorder
A
- Personality trait
- An enduring, repetitive pattern of perceiving, relating to, and thinking about the environment and oneself.
- Personality disorder
- Inflexible, maladaptive, and rigidly pervasive pattern of behavior causing subjective distress and/ or impaired functioning
- Person is usually not aware of problem.
- Usually presents by early adulthood.
- Three clusters, A, B, and C
- Remember as Weird, Wild, and Worried based on symptoms.
9
Q
Cluster A personality disorders
- Definition
- Disorders
A
- Definition
- Odd or eccentric
- Inability to develop meaningful social relationships.
- No psychosis
- Genetic association with schizophrenia.
- “Weird” (Accusatory, Aloof, Awkward).
- Disorders
- Paranoid
- Schizoid
- Schizotypal
10
Q
Cluster A personality disorders
- Paranoid
- Schizoid
- Schizotypal
A
- Paranoid
- Pervasive distrust and suspiciousness
- Projection is the major defense mechanism.
- Schizoid
- Voluntary social withdrawal, limited emotional expression, content with social isolation (vs. avoidant).
- Schizoid** = distant.**
- Schizotypal
- Eccentric appearance, odd beliefs or magical thinking, interpersonal awkwardness.
- Schizotypal = magical thinking.
11
Q
Cluster B personality disorders
- Definition
- Disorders
A
- Definition
- Dramatic, emotional, or erratic
- Genetic association with mood disorders and substance abuse.
- “Wild” (Bad to the Bone).
- Disorders
- Antisocial
- Borderline
- Histrionic
- Narcissistic
12
Q
Cluster B personality disorders
- Antisocial
- Borderline
- Histrionic
- Narcissistic
A
- Antisocial
- Disregard for and violation of rights of others, criminality, impulsivity
- Males > females
- Must be > 18 years old and have history of conduct disorder before age 15.
- Conduct disorder if < 18 years old.
- Antisocial = sociopath.
- Borderline
- Unstable mood and interpersonal relationships, impulsiveness, self-mutilation, boredom, sense of emptiness
- Females > males
- Splitting is a major defense mechanism.
- Histrionic
- Excessive emotionality and excitability, attention seeking, sexually provocative, overly concerned with appearance.
- Narcissistic
- Grandiosity, sense of entitlement
- Lacks empathy and requires excessive admiration
- Often demands the “best” and reacts to criticism with rage.
13
Q
Cluster C personality disorders
- Definition
- Disorders
A
- Definition
- Anxious or fearful
- Genetic association with anxiety disorders.
- “Worried” (Cowardly, Compulsive, Clingy).
- Disorders
- Avoidant
- Obsessive-compulsive
- Dependent
14
Q
Cluster C personality disorders
- Avoidant
- Obsessive-compulsive
- Dependent
A
- Avoidant
- Hypersensitive to rejection, socially inhibited, timid, feelings of inadequacy, desires relationships with others (vs. schizoid).
- Obsessive-compulsive
- Preoccupation with order, perfectionism, and control
- Ego-syntonic: behavior consistent with one’s own beliefs and attitudes (vs. OCD).
- Dependent
- Submissive and clinging, excessive need to be taken care of, low self-confidence.
15
Q
Schizo-
- -id vs. -typal vs. -phrenic vs. -affective
- Schizophrenia time course
A
- Schizoid < Schizotypal < Schizophrenic < Schizoaffective
- Schizotypal = schizoid + odd thinking
- Schizophrenic = greater odd thinking than schizotypal
- Schizoaffective = schizophrenic psychotic symptoms + bipolar or depressive mood disorder
- Schizophrenia time course
- < 1 mo—brief psychotic disorder, usually stress related
- 1–6 mo—schizophreniform disorder
- > 6 mo—schizophrenia
16
Q
Eating disorders
- Anorexia nervosa
- Definition
- Findings
- Bulimia nervosa
- Definition
- Findings
A
- Anorexia nervosa
- Definition
- Excessive dieting +/− purging
- Intense fear of gaining weight, body image distortion, and increased exercise, leading to a body weight well below ideal (≈ BMI < 17 kg/m2).
- Seen primarily in adolescent girls
- Findings
- Associated with decreased bone density.
- Severe weight loss, metatarsal stress fractures, amenorrhea, lanugo (fine body hair), anemia, and electrolyte disturbances.
- Osteoporosis caused in part by decreased estrogen over time.
- Commonly coexists with depression.
- Definition
- Bulimia nervosa
- Definition
- Binge eating +/− purging
- Often followed by self-induced vomiting or use of laxatives, diuretics, or emetics.
- Body weight often maintained within normal range.
- Seen predominantly in adolescent girls
- Findings
- Associated with parotitis, enamel erosion, electrolyte disturbances, alkalosis, dorsal hand calluses from induced vomiting (Russell sign).
- Definition
17
Q
Gender dysphoria
- Definition
- Transsexualism
- Transvestism
A
- Definition
- Strong, persistent cross-gender identification.
- Characterized by persistent discomfort with one’s sex assigned at birth, causing significant distress and/or impaired functioning.
- Affected individuals are often referred to as transgender.
-
Transsexualism
- Desire to live as the opposite sex, often through surgery or hormone treatment.
-
Transvestism
- Paraphilia, not gender dysphoria.
- Wearing clothes (e.g., vest) of the opposite sex (cross-dressing)
18
Q
Sexual dysfunction
- Includes:
- Differential diagnosis includes:
A
- Includes:
- Sexual desire disorders (hypoactive sexual desire or sexual aversion)
- Sexual arousal disorders (erectile dysfunction)
- Orgasmic disorders (anorgasmia and premature ejaculation)
- Sexual pain disorders (dyspareunia and vaginismus).
- Differential diagnosis includes:
- Drugs (e.g., antihypertensives, neuroleptics, SSRIs, ethanol)
- Diseases (e.g., depression, diabetes, STDs)
- Psychological (e.g., performance anxiety)
19
Q
Sleep terror disorder
A
- Periods of terror with screaming in the middle of the night
- Most common in children.
- Occurs during slow-wave sleep.
- Occurs during non-REM sleep (no memory of arousal) as opposed to nightmares that occur during REM sleep (memory of a scary dream).
- Cause unknown, but triggers may include emotional stress, fever, or lack of sleep.
- Usually self limited.
20
Q
Narcolepsy
- Definition
- Also associated with:
- Treatment
A
- Definition
- Disordered regulation of sleep-wake cycles
- 1° characteristic is excessive daytime sleepiness.
- Caused by decreased orexin production in lateral hypothalamus.
- Strong genetic component.
- Also associated with:
- Hypnagogic (just before sleep) or hypnopompic (just before awakening) hallucinations.
- Hypnagogic—going to sleep
- Hypnopompic—post-sleep
- Nocturnal and narcoleptic sleep episodes that start off with REM sleep.
- Cataplexy (loss of all muscle tone following a strong emotional stimulus, such as laughter) in some patients.
- Hypnagogic (just before sleep) or hypnopompic (just before awakening) hallucinations.
- Treatment
- Daytime stimulants (e.g., amphetamines, modafinil) and nighttime sodium oxybate (GHB).
21
Q
Substance use disorder
A
- Maladaptive pattern of substance use defined as 2 or more of the following signs in 1 year:
- Tolerance—need more to achieve same effect
- Withdrawal
- Substance taken in larger amounts, or over longer time, than desired
- Persistent desire or unsuccessful attempts to cut down
- Significant energy spent obtaining, using, or recovering from substance
- Important social, occupational, or recreational activities reduced because of substance use
- Continued use in spite of knowing the problems that it causes
- Craving
- Recurrent use in physically dangerous situations
- Failure to fulfill major obligations at work, school, or home due to use
- Social or interpersonal conflicts related to substance use
22
Q
Stages of change in overcoming substance addiction
A
-
Precontemplation
- Not yet acknowledging that there is a problem
-
Contemplation
- Acknowledging that there is a problem, but not yet ready or willing to make a change
-
Preparation/determination
- Getting ready to change behavior
-
Action/willpower
- Changing behaviors
-
Maintenance
- Maintaining the behavior change
-
Relapse
- Returning to old behaviors and abandoning new changes
23
Q
Nonspecific depressants
- Type of drug
- Intoxication symptoms
- Withdrawal symptoms
A
- Type of drug
- Psychoactive drugs: depressants
- Intoxication symptoms
- Nonspecific: mood elevation, decreased anxiety, sedation, behavioral disinhibition, respiratory depression.
- Withdrawal symptoms
- Nonspecific: anxiety, tremor, seizures, insomnia.
24
Q
Alcohol
- Type of drug
- Intoxication
- Symptoms
- Labs
- Withdrawal
- Symptoms
- Treatment
A
- Type of drug
- Psychoactive drug: depressant
- Intoxication
- Emotional lability, slurred speech, ataxia, coma, blackouts.
- Labs
- Serum γ-glutamyltransferase (GGT)—sensitive indicator of alcohol use.
- Lab AST value is twice ALT value.
- Withdrawal
- Symptoms
- Mild alcohol withdrawal: symptoms similar to other depressants.
- Severe alcohol withdrawal can cause autonomic hyperactivity and DTs (5–15% mortality rate).
- Treatment for DTs: benzodiazepines.
- Symptoms
25
Opioids (e.g., morphine, heroin, methadone)
* Type of drug
* Intoxication
* Symptoms
* Treatment
* Withdrawal
* Symptoms
* Treatment
* Type of drug
* Psychoactive drugs: depressants
* Intoxication
* Euphoria, respiratory and CNS depression, decreased gag reflex, pupillary constriction (pinpoint pupils), seizures (overdose).
* Treatment: naloxone, naltrexone.
* Withdrawal
* Sweating, dilated pupils, piloerection (“cold turkey”), fever, rhinorrhea, yawning, nausea, stomach cramps, diarrhea (“flu-like” symptoms).
* Treatment: long-term support, methadone, buprenorphine.
26
Barbiturates
* Type of drug
* Intoxication
* Symptoms
* Treatment
* Withdrawal symptoms
* Type of drug
* Psychoactive drugs: depressants
* Intoxication
* Low safety margin, marked respiratory depression.
* Treatment: symptom management (assist respiration, increase BP).
* Withdrawal symptoms
* Delirium, life-threatening cardiovascular collapse.
27
Benzodiazepines
* Type of drug
* Intoxication
* Symptoms
* Treatment
* Withdrawal symptoms
* Type of drug
* Psychoactive drugs: depressants
* Intoxication
* Symptoms
* Greater safety margin.
* Ataxia, minor respiratory depression.
* Treatment: supportive care; consider flumazenil (competitive benzodiazepine antagonist).
* Withdrawal symptoms
* Sleep disturbance, depression, rebound anxiety, seizure (can be triggered by reversal with flumazenil).
28
Nonspecific stimulants
* Type of drug
* Intoxication symptoms
* Withdrawal symptoms
* Type of drug
* Psychoactive drugs: stimulants
* Intoxication symptoms
* Nonspecific: mood elevation, psychomotor agitation, insomnia, cardiac arrhythmias, tachycardia, anxiety.
* Withdrawal symptoms
* Nonspecific: post-use “crash,” including depression, lethargy, weight gain, headache.
29
Amphetamines
* Type of drug
* Intoxication symptoms
* Withdrawal symptoms
* Type of drug
* Psychoactive drugs: stimulants
* Intoxication symptoms
* Euphoria, grandiosity, pupillary dilation, prolonged wakefulness and attention, hypertension, tachycardia, anorexia, paranoia, fever.
* Severe: cardiac arrest, seizure.
* Withdrawal symptoms
* Anhedonia, increased appetite, hypersomnolence, existential crisis.
30
Cocaine
* Type of drug
* Intoxication
* Symptoms
* Treatment
* Withdrawal symptoms
* Type of drug
* Psychoactive drug: stimulant
* Intoxication
* Impaired judgment, pupillary dilation, hallucinations (including tactile), paranoid ideations, angina, sudden cardiac death.
* Treatment: benzodiazepines.
* Withdrawal symptoms
* Hypersomnolence, malaise, severe psychological craving, depression/suicidality.
31
Caffeine
* Type of drug
* Intoxication symptoms
* Withdrawal symptoms
* Type of drug
* Psychoactive drug: stimulant
* Intoxication symptoms
* Restlessness, increased diuresis, muscle twitching.
* Withdrawal symptoms
* Lack of concentration, headache.
32
Nicotine
* Type of drug
* Intoxication symptoms
* Withdrawal
* Symptoms
* Treatment
* Type of drug
* Psychoactive drugs: stimulants
* Intoxication symptoms
* Restlessness.
* Withdrawal
* Irritability, anxiety, craving.
* Treatment: nicotine patch, gum, or lozenges; bupropion/ varenicline.
33
PCP
* Type of drug
* Intoxication
* Symptoms
* Treatment
* Withdrawal symptoms
* Type of drug
* Psychoactive drug: hallucinogen
* Intoxication
* Belligerence, impulsiveness, fever, psychomotor agitation, analgesia, vertical and horizontal nystagmus, tachycardia, homicidality, psychosis, delirium, seizures.
* Treatment: benzodiazepines, rapid-acting antipsychotic.
* Withdrawal symptoms
* Depression, anxiety, irritability, restlessness, anergia, disturbances of thought and sleep.
34
LSD
* Type of drug
* Intoxication symptoms
* Withdrawal symptoms
* Type of drug
* Psychoactive drug: hallucinogen
* Intoxication symptoms
* Perceptual distortion (visual, auditory), depersonalization, anxiety, paranoia, psychosis, possible flashbacks.
* Withdrawal symptoms
* None
35
Marijuana (cannabinoid)
* Type of drug
* Intoxication symptoms
* Withdrawal symptoms
* Type of drug
* Psychoactive drug: hallucinogen
* Intoxication symptoms
* Euphoria, anxiety, paranoid delusions, perception of slowed time, impaired judgment, social withdrawal, increased appetite, dry mouth, conjunctival injection, hallucinations.
* Prescription form is dronabinol (tetrahydrocannabinol isomer): used as antiemetic (chemotherapy) and appetite stimulant (in AIDS).
* Withdrawal symptoms
* Irritability, depression, insomnia, nausea, anorexia.
* Most symptoms peak in 48 hours and last for 5–7 days.
* Generally detectable in urine for 4–10 days.
36
Heroin addiction
* Definition
* Treatments
* Methadone
* Naloxone + buprenorphine
* Naltrexone
* Definition
* Users at increased risk for hepatitis, abscesses, overdose, hemorrhoids, AIDS, and right-sided endocarditis.
* Look for track marks (needle sticks in veins).
* Treatments
* Methadone
* Long-acting oral opiate
* Used for heroin detoxification or long-term maintenance.
* Naloxone + buprenorphine
* Partial agonist
* Long acting with fewer withdrawal symptoms than methadone.
* Naloxone is not active when taken orally, so withdrawal symptoms occur only if injected (lower abuse potential).
* Naltrexone
* Long-acting opioid antagonist used for relapse prevention once detoxified.
37
Alcoholism
* Definition
* Complications
* Treatment
* Definition
* Physiologic tolerance and dependence with symptoms of withdrawal (tremor, tachycardia, hypertension, malaise, nausea, DTs) when intake is interrupted.
* Complications
* Alcoholic cirrhosis, hepatitis, pancreatitis, peripheral neuropathy, testicular atrophy.
* Treatment
* Disulfiram (to condition the patient to abstain from alcohol use), naltrexone, supportive care.
* Alcoholics Anonymous and other peer support groups are helpful in sustaining abstinence.
38
Wernicke-Korsakoff syndrome
* Definition
* Findings
* Treatment
* Definition
* Alcoholism
* Caused by thiamine deficiency.
* Findings
* Triad of confusion, ophthalmoplegia, and ataxia (**Wernicke encephalopathy**).
* May progress to irreversible memory loss, confabulation, personality change (**Korsakoff psychosis**).
* Associated with periventricular hemorrhage/necrosis of mammillary bodies.
* Treatment
* IV vitamin B1 (thiamine).
39
Mallory-Weiss syndrome
* Definition
* Findings
* Definition
* Alcoholism
* Longitudinal partial thickness tear at the gastroesophageal junction caused by excessive vomiting.
* Findings
* Often presents with hematemesis.
* Associated with pain (vs. esophageal varices).
40
Delirium tremens (DTs)
* Definition
* Findings
* Treatment
* Definition
* Life-threatening alcohol withdrawal syndrome that peaks 2–5 days after last drink.
* Symptoms in order of appearance
* Autonomic system hyperactivity (tachycardia, tremors, anxiety, seizures)
* Psychotic symptoms (hallucinations, delusions)
* Confusion
* Treatment
* Benzodiazepines.